Net income
-88 million USD
2022-10-01 – 2023-09-30
Fundies. English
LianBio
EDGAR17 filing records in this dataset, filed from 2021-10-01 to 2024-02-20. Reported financial figures are available; chart coverage varies by period.
- Cash and cash equivalents
- 103 million USD Source
Exact value
103457000 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 107 million shares Source
Exact value
107168686 shares
Reported share-count change
-1.09% · -1.19 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Operating cash flow
-83.5 million USD
2022-10-01 – 2023-09-30
Exact inputs and evidence
- Operating cash flow: -99185000 USD · 2022-01-01 – 2022-12-31 Source
- Operating cash flow: -68472000 USD · 2022-01-01 – 2022-09-30 Source
- Operating cash flow: -17632000 USD · 2023-01-01 – 2023-03-31 Source
- Operating cash flow: -36950000 USD · 2023-01-01 – 2023-06-30 Source
- Operating cash flow: -17632000 USD · 2023-01-01 – 2023-03-31 Source
- Operating cash flow: -52814000 USD · 2023-01-01 – 2023-09-30 Source
- Operating cash flow: -36950000 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure
464 thousand USD
2022-10-01 – 2023-09-30
Exact inputs and evidence
- Capital expenditure: 1845000 USD · 2022-01-01 – 2022-12-31 Source
- Capital expenditure: 1610000 USD · 2022-01-01 – 2022-09-30 Source
- Capital expenditure: 19000 USD · 2023-01-01 – 2023-03-31 Source
- Capital expenditure: 69000 USD · 2023-01-01 – 2023-06-30 Source
- Capital expenditure: 19000 USD · 2023-01-01 – 2023-03-31 Source
- Capital expenditure: 229000 USD · 2023-01-01 – 2023-09-30 Source
- Capital expenditure: 69000 USD · 2023-01-01 – 2023-06-30 Source
Free cash flow
-84 million USD
2022-10-01 – 2023-09-30
Exact inputs and evidence
- Operating cash flow: -99185000 USD · 2022-01-01 – 2022-12-31 Source
- Operating cash flow: -68472000 USD · 2022-01-01 – 2022-09-30 Source
- Operating cash flow: -17632000 USD · 2023-01-01 – 2023-03-31 Source
- Operating cash flow: -36950000 USD · 2023-01-01 – 2023-06-30 Source
- Operating cash flow: -17632000 USD · 2023-01-01 – 2023-03-31 Source
- Operating cash flow: -52814000 USD · 2023-01-01 – 2023-09-30 Source
- Operating cash flow: -36950000 USD · 2023-01-01 – 2023-06-30 Source
- Capital expenditure: 1845000 USD · 2022-01-01 – 2022-12-31 Source
- Capital expenditure: 1610000 USD · 2022-01-01 – 2022-09-30 Source
- Capital expenditure: 19000 USD · 2023-01-01 – 2023-03-31 Source
- Capital expenditure: 69000 USD · 2023-01-01 – 2023-06-30 Source
- Capital expenditure: 19000 USD · 2023-01-01 – 2023-03-31 Source
- Capital expenditure: 229000 USD · 2023-01-01 – 2023-09-30 Source
- Capital expenditure: 69000 USD · 2023-01-01 – 2023-06-30 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2024-02-20.
Financial data available through: 2022-12-31.
Coverage by financial measure
- revenue: No compatible figures in this window
- Operating income: 3 of 11 periods available· newest 2022-12-31
- Net income: 3 of 11 periods available· newest 2022-12-31
- Operating cash flow: 3 of 11 periods available· newest 2022-12-31
- Capital expenditure: 3 of 11 periods available· newest 2022-12-31
- Total assets: 3 of 11 periods available· newest 2022-12-31
- Total liabilities: 3 of 11 periods available· newest 2022-12-31
- Current assets: 3 of 11 periods available· newest 2022-12-31
- Current liabilities: 3 of 11 periods available· newest 2022-12-31
- Cash and cash equivalents: 3 of 11 periods available· newest 2022-12-31
- long term debt: No compatible figures in this window
- Shares outstanding: 3 of 11 periods available· newest 2022-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Net income
+USD 86.01 millionPrior period
−USD 196.3 million
–
Current period
−USD 110.29 million
–
Exact inputs and evidence
-110290000 − -196300000 = 86010000 USD
-196300000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source-110290000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 64.77 millionPrior period
−USD 163.95 million
–
Current period
−USD 99.19 million
–
Exact inputs and evidence
-99185000 − -163953000 = 64768000 USD
-163953000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source-99185000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+94.8%Prior period
USD 947,000
–
Current period
USD 1.85 million
–
Exact inputs and evidence
1845000 − 947000 = 898000 USD
947000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source1845000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Revenue growth
Change in revenue from the same financial period one year earlier.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Not enough comparable data to show this history.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|
Operating cash flow
Cash generated by the company’s normal business operations.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Current assets to current liabilities
Current assets divided by current liabilities.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2020 2020-01-01 – 2020-12-31 | −USD 139.6 million Exact valueExact value: -139604000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 98.14 million Exact valueExact value: -98142000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 886,000 Exact valueExact value: 886000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 99.03 million Calculation and evidence-98142000 − 886000 USD Exact free cash flow: -99028000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2021 2021-01-01 – 2021-12-31 | −USD 196.3 million Exact valueExact value: -196300000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 163.95 million Exact valueExact value: -163953000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 947,000 Exact valueExact value: 947000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 164.9 million Calculation and evidence-163953000 − 947000 USD Exact free cash flow: -164900000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2022-01-01 – 2022-12-31 | −USD 110.29 million Exact valueExact value: -110290000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 99.19 million Exact valueExact value: -99185000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.85 million Exact valueExact value: 1845000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 101.03 million Calculation and evidence-99185000 − 1845000 USD Exact free cash flow: -101030000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
17 filings · 715 latest values · 715 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001831283, 1831283, LIAN, LIANY, edgar:1831283
Also known as LianBio